MPN Working Group: Practical Applications for Nurses to Improve Patient Outcomes and Next Steps to Move the Field Forward

Release Date: May 13, 2021
Expiration Date:  May 13, 2022

Activity Overview

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Incyte Corporation.
 

Target Audience

This educational activity is directed toward nurses and other health care professionals with an interest in the treatment of hematologic malignancies.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Explain the pathological mechanisms, diagnostic criteria, and risk stratification methods in MPNs
• Evaluate clinical trial data regarding current and emerging therapies for the treatment of MPNs
• Implement strategies to monitor and mitigate toxicities associated with therapeutic agents for MPNs
• Apply nursing strategies to manage the care of MPNs in the context of counselling on treatment-related toxicities and supportive care interventions

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible entities.

Faculty

Daniel J. DeAngelo, MD, PhD
Chief, Division of Leukemia, Dana-Farber Cancer Institute
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, MA

Disclosures:Grant Research Support: AbbVie, Blueprint, GlycoMimetics, Novartis; Consultant: AbbVie, Amgen, Agios Pharmaceuticals, Autolus Therapeutics, Blueprint, Forty Seven, GlycoMimetics, Incyte Corp, Jazz Pharmaceuticals, Kite Pharma, Novartis, Pfizer, Servier Laboratories, Takeda Pharmaceutical Co

Ilene Galinsky, MSN, BSN, ANP-C
Senior Program Research Nurse Practitioner
Dana-Farber Cancer Institute
Boston, MA

Disclosures:Consultant: AbbVie, Novartis, Pfizer

Sandra Kurtin, PhD, ANP-C, AOCN
Director, Advanced Practice and Clinical Integration
Nurse Practitioner
The University of Arizona Cancer Center
Assistant Professor of Clinical Medicine
Adjunct Clinical Assistant Professor of Nursing
The University of Arizona
Tucson, AZ

Disclosures:Consultant: AbbVie, Amgen, Bristol Myers Squibb, Incyte Corp

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.